Glenn Welling - Engaged Capital
Holding/activity history for Evolent Health Inc. (EVH)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 5,563,912 | 4.18 | $2.28 | $12,685,719 | SEC | ||
| 2025 Q4 | 5,563,912 | 5.68 | Reduce 1.77% | 0.21 | $4.00 | $22,255,648 | SEC |
| 2025 Q3 | 5,663,912 | 11.75 | Reduce 3.25% | 0.60 | $8.46 | $47,916,696 | SEC |
| 2025 Q2 | 5,854,468 | 18.43 | Add 13.03% | 2.12 | $11.26 | $65,921,310 | SEC |
| 2025 Q1 | 5,179,468 | 12.50 | Reduce 4.17% | 0.52 | $9.47 | $49,049,562 | SEC |
| 2024 Q4 | 5,404,768 | 12.50 | Add 35.48% | 3.27 | $11.25 | $60,803,640 | SEC |
| 2024 Q3 | 3,989,468 | 18.30 | Reduce 2.97% | 0.40 | $28.28 | $112,822,155 | SEC |
| 2024 Q2 | 4,111,458 | 13.46 | Add 26.06% | 2.78 | $19.12 | $78,611,077 | SEC |
| 2024 Q1 | 3,261,458 | 17.33 | $32.79 | $106,943,208 | SEC | ||
| 2023 Q4 | 3,261,458 | 15.78 | Add 15.13% | 2.07 | $33.03 | $107,725,958 | SEC |
| 2023 Q3 | 2,832,810 | 14.06 | Add 62.13% | 5.39 | $27.23 | $77,137,416 | SEC |
| 2023 Q2 | 1,747,252 | 7.66 | Reduce 21.06% | 2.15 | $30.30 | $52,941,736 | SEC |
| 2023 Q1 | 2,213,454 | 10.22 | Reduce 20.55% | 2.72 | $32.45 | $71,826,582 | SEC |
| 2022 Q4 | 2,786,042 | 13.23 | Add 24.27% | 2.58 | $28.08 | $78,232,059 | SEC |
| 2022 Q3 | 2,241,992 | 15.93 | Reduce 63.57% | 18.45 | $35.93 | $80,555,000 | SEC |
| 2022 Q2 | 6,154,821 | 29.02 | Reduce 13.88% | 3.24 | $30.71 | $189,015,000 | SEC |
| 2022 Q1 | 7,146,395 | 23.37 | Reduce 8.73% | 2.33 | $32.30 | $230,829,000 | SEC |
| 2021 Q4 | 7,829,692 | 26.68 | Reduce 0.80% | 0.14 | $27.67 | $216,648,000 | SEC |
| 2021 Q3 | 7,893,194 | 17.58 | Reduce 7.72% | 1.08 | $31.00 | $244,689,000 | SEC |
| 2021 Q2 | 8,553,155 | 13.99 | $21.12 | $180,643,000 | SEC | ||
| 2021 Q1 | 8,553,155 | 12.48 | $20.20 | $172,774,000 | SEC | ||
| 2020 Q4 | 8,553,155 | 11.31 | $16.03 | $137,107,000 | SEC | ||
| 2020 Q3 | 8,553,155 | 10.98 | Buy | 10.98 | $12.41 | $106,145,000 | SEC |